Cambium Bio Limited Stock: price and insider trades · Australia
Cambium Bio Limited: what insiders have been doing
Every trade that managers of Cambium Bio Limited disclose to ASX is tracked on this page. The company sits in the Health Care sector. In the past year (31 October 2025 to 31 October 2026), 6 filings came from 4 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Over the last twelve months, not one insider purchase of Cambium Bio Limited stock was filed.
With 6 filings in twelve months, the company is more active than the median of 5 filings across the 1,612 companies we follow on the same exchange.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Source: insider filings from ASX. Past trades are no guide to future returns.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- ●Executives0ASX
- ●Executives0ASX
- ShareASXISIN AU0000327769ASX:2924-03113867-2A1685731
- ●Executives0ASX
- ShareASXISIN AU0000327769ASX:2924-03103325-2A1678949
- ●Executives0ASX
6 of 6 declarations
About Cambium Bio Limited
Cambium Bio Limited is a company listed on the XASX, focused on developing biological solutions for agriculture. It emphasizes sustainable innovation and improving agricultural yields.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
